Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 3 | 47D3S | IM / LA |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | 2 | W1C751M | IM / RA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | 2 | X018902 | SC / LA |
Vaccine appointment, review eligibility, contraindications and VIS. Vaccine preparation, administration and documentation. Scanned files into nightingale notes. Administered Hep B, without apparent reactions. Administered MMR and patient appeared pale and unsteady. He was able to stand and change sides without apparent difficulties. Administered Polio vaccine and placed band aid, patient appeared to faint, eyes remained open but slid off chair, forward onto knees. Guardian and writer were able to hold him steady with no apparent injuries. He was able to state name, birthday and reported feeling dizzy/lightheaded. Remained sitting on the floor, asked for water. Writer called (co worker) for additional support. Patient was able to stand and sit in chair. Vitals taken 98% O2, 74 P, 16RR and 118/68 BP. Remained with patient for 30 min, appeared comfortable and left for home. To call as needed.
None reported.
None known.
None known.
None known.
None completed. Pt appears to have recovered, no other reactions reported.